Skip to content
Home/Companies/Biotech/Renovacor
RE

Renovacor

Biotech·United States·Exited 2022·Held 3yr

Renovacor is a biotech company, headquartered in United States.

Entry
2019
Hold
3yr
Exit
2022
Est. EV
–

Who owns Renovacor?

Renovacor was owned by Innogest SGR through Innogest Capital II (2015 vintage) from 2019 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-23

Innogest SGR
Investor
Innogest SGR
Innogest Capital II · 2015 · VC

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Innogest Capital II

Other portfolio companies in the same fund.

Affera
Exited 2022
MedTechUnited States· 2021
to
MioAssicuratore
Active
InsurTechItaly· 2018
Soul-K
Active
FoodTechItaly· 2018
Anaconda Biomed
Active
MedTechSpain· 2017
Greenbone
Active
MedTechItaly· 2017
Medlumics
Active
MedTechSpain· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings